Company intelligence / Profile preview

TransPacific Venture Partners

Ownership: Private
Development stage: Other

Overview

TransPacific Venture Partners (TPV) is an Asia-based venture capital firm specializing in early-stage investments in medical technology and healthcare startups. The firm leverages deep expertise in medicine, engineering, and venture investing to identify unmet needs and support the growth of medtech innovations across Asia. TPV typically invests between $500K and $3 million per company and maintains reserves for follow-on financing[2]. The team includes experienced leaders from both the medical device industry and academia[1].

Industry: Investors

Partnerships

Strategic partners across Asia supporting clinical, technical, and strategic development for portfolio companies

Beyond the preview

Go deeper on TransPacific Venture Partners.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TransPacific Venture Partners.

Explore the full profile